2. Academic Validation
  3. A metabolomic profile is associated with the risk of incident coronary heart disease

A metabolomic profile is associated with the risk of incident coronary heart disease

  • Am Heart J. 2014 Jul;168(1):45-52.e7. doi: 10.1016/j.ahj.2014.01.019.
Anika A M Vaarhorst 1,  Aswin Verhoeven 2,  Claudia M Weller 3,  Stefan Böhringer 4,  Sibel Göraler 2,  Axel Meissner 2,  André M Deelder 2,  Peter Henneman 3,  Anton P M Gorgels 5,  Piet A van den Brandt 6,  Leo J Schouten 7,  Marleen M van Greevenbroek 8,  Audrey H H Merry 9,  W M Monique Verschuren 10,  Arn M J M van den Maagdenberg 11,  Ko Willems van Dijk 12,  Aaron Isaacs 13,  Dorret Boomsma 14,  Ben A Oostra 13,  Cornelia M van Duijn 13,  J Wouter Jukema 15,  Jolanda M A Boer 10,  Edith Feskens 16,  Bastiaan T Heijmans 17,  P Eline Slagboom 18
Affiliations

Affiliations

  • 1 Department of Molecular Epidemiology, Leiden University Medical Center, Leiden, The Netherlands. Electronic address: a.a.m.vaarhorst@lumc.nl.
  • 2 Department of Parasitology, Leiden University Medical Center, Leiden, The Netherlands.
  • 3 Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.
  • 4 Department of Medical Statistics, Leiden University Medical Center, Leiden, The Netherlands.
  • 5 Department of Cardiology, Maastricht University Medical Centre, Maastricht, The Netherlands.
  • 6 Department of Epidemiology (CAPHRI School for Public Health and Primary Care), Maastricht University, Maastricht, The Netherlands; Department of Epidemiology (GROW School of Oncology and Developmental Biology), Maastricht University, Maastricht, The Netherlands.
  • 7 Department of Epidemiology (GROW School of Oncology and Developmental Biology), Maastricht University, Maastricht, The Netherlands.
  • 8 Department of Internal Medicine (CARIM School for Cardiovascular diseases), Maastricht University Medical Centre, Maastricht, The Netherlands.
  • 9 Department of Epidemiology (CAPHRI School for Public Health and Primary Care), Maastricht University, Maastricht, The Netherlands.
  • 10 National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
  • 11 Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands; Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.
  • 12 Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands; Department of Endocrinology, Leiden University Medical Center, Leiden, The Netherlands.
  • 13 Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands.
  • 14 Biological Psychology, VU University, Amsterdam, The Netherlands.
  • 15 Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands; The Durrer Center for Cardiogenetic Research, Amsterdam, The Netherlands; Interuniversity Cardiology Institute of the Netherlands (ICIN), Utrecht, The Netherlands.
  • 16 Division of Human Nutrition, Wageningen University and Research Center, Wageningen, The Netherlands.
  • 17 Department of Molecular Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.
  • 18 Department of Molecular Epidemiology, Leiden University Medical Center, Leiden, The Netherlands; Netherlands Consortium for Healthy Ageing, Leiden, The Netherlands. Electronic address: P.Slagboom@lumc.nl.
PMID: 24952859 DOI: 10.1016/j.ahj.2014.01.019
Abstract

Background: Metabolomics, defined as the comprehensive identification and quantification of low-molecular-weight metabolites to be found in a biological sample, has been put forward as a potential tool for classifying individuals according to their risk of coronary heart disease (CHD). Here, we investigated whether a single-point blood measurement of the metabolome is associated with and predictive for the risk of CHD.

Methods and results: We obtained proton nuclear magnetic resonance spectra in 79 cases who developed CHD during follow-up (median 8.1 years) and in 565 randomly selected individuals. In these spectra, 100 signals representing 36 metabolites were identified. Applying least absolute shrinkage and selection operator regression, we defined a weighted metabolite score consisting of 13 proton nuclear magnetic resonance signals that optimally predicted CHD. This metabolite score, including signals representing a lipid fraction, glucose, valine, ornithine, glutamate, creatinine, glycoproteins, citrate, and 1.5-anhydrosorbitol, was associated with the incidence of CHD independent of traditional risk factors (TRFs) (hazard ratio 1.50, 95% CI 1.12-2.01). Predictive performance of this metabolite score on its own was moderate (C-index 0.75, 95% CI 0.70-0.80), but after adding age and sex, the C-index was only modestly lower than that of TRFs (C-index 0.81, 95% CI 0.77-0.85 and C-index 0.82, 95% CI 0.78-0.87, respectively). The metabolite score was also associated with prevalent CHD independent of TRFs (odds ratio 1.59, 95% CI 1.19-2.13).

Conclusion: A metabolite score derived from a single-point metabolome measurement is associated with CHD, and metabolomics may be a promising tool for refining and improving the prediction of CHD.

Figures
Products